US 10035833
Vascular endothelial growth factor antagonists and methods of making
granted A61KA61K38/1866
Quick answer
US patent 10035833 (Vascular endothelial growth factor antagonists and methods of making) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/1866